{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:13:50Z","timestamp":1787948030686,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"publisher","award":["WI219567"],"award-info":[{"award-number":["WI219567"]}],"id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12020-019-01847-7","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T14:03:41Z","timestamp":1553263421000},"page":"330-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Healthcare utilization and costs among patients with non-functioning pituitary adenomas"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2523-8707","authenticated-orcid":false,"given":"Daniel J.","family":"Lobatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert B.","family":"van den Hout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir H.","family":"Zamanipoor Najafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anath N. V.","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelie D.","family":"Andela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilco C.","family":"Peul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter R.","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea P. M.","family":"Vliet Vlieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"1847_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","volume":"18","author":"CD Andela","year":"2015","unstructured":"C.D. Andela, M. Scharloo, A.M. Pereira et al. Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18, 752\u2013776 (2015)","journal-title":"Pituitary"},{"key":"1847_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11102-017-0860-4","volume":"21","author":"CD Andela","year":"2018","unstructured":"C.D. Andela, D.J. Lobatto, A.M. Pereira et al. How non-functioning pituitary adenomas can affect health-related quality of life: a conceptual model and literature review. Pituitary 21, 208\u2013216 (2018)","journal-title":"Pituitary"},{"key":"1847_CR3","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1210\/jc.2006-0003","volume":"91","author":"OM Dekkers","year":"2006","unstructured":"O.M. Dekkers, A.A. van der Klaauw, A.M. Pereira et al. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 91, 3364\u20133369 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1847_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","volume":"69","author":"AA Klaauw van der","year":"2008","unstructured":"A.A. van der Klaauw, M. Kars, N.R. Biermasz et al. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin. Endocrinol. (Oxf.). 69, 775\u2013784 (2008)","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"1847_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ando.2012.03.039","volume":"73","author":"N Karavitaki","year":"2012","unstructured":"N. Karavitaki, Prevalence and incidence of pituitary adenomas. Ann. Endocrinol. (Paris) 73, 79\u201380 (2012)","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"1847_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s11102-015-0654-5","volume":"18","author":"MS Broder","year":"2015","unstructured":"M.S. Broder, M.P. Neary, E. Chang, W.H. Ludlam, Incremental healthcare resource utilization and costs in US patients with Cushing\u2019s disease compared with diabetes mellitus and population controls. Pituitary 18, 796\u2013802 (2015)","journal-title":"Pituitary"},{"key":"1847_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11102-013-0506-0","volume":"17","author":"MS Broder","year":"2014","unstructured":"M.S. Broder, M.P. Neary, E. Chang et al. Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases. Pituitary 17, 333\u2013341 (2014)","journal-title":"Pituitary"},{"key":"1847_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4158\/EP14126.OR","volume":"21","author":"MS Broder","year":"2015","unstructured":"M.S. Broder, M.P. Neary, E. Chang et al. Burden of illness, annual healthcare utilization, and costs associated with commercially insured patients with cushing disease in the United States. Endocr. Pract. 21, 77\u201386 (2015)","journal-title":"Endocr. Pract."},{"key":"1847_CR9","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/BF03345306","volume":"27","author":"G Didoni","year":"2004","unstructured":"G. Didoni, S. Grottol, V. Gasco et al. Cost-of-illness study in acromegalic patients in Italy. J. Endocrinol. Invest. 27, 1034\u20131039 (2004)","journal-title":"J. Endocrinol. Invest."},{"key":"1847_CR10","first-page":"1106","volume":"21","author":"H Placzek","year":"2015","unstructured":"H. Placzek, Y. Xu, Y. Mu et al. Clinical and economic burden of commercially insured patients with acromegaly in the United States: A retrospective analysis. J. Manag Care Spec. Pharm. 21, 1106\u20131114 (2015)","journal-title":"J. Manag Care Spec. Pharm."},{"key":"1847_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4158\/EP10368.OR","volume":"17","author":"B Swearingen","year":"2011","unstructured":"B. Swearingen, N. Wu, S.Y. Chen et al. Health care resource use and costs among patients with cushing disease. Endocr. Pract. 17, 681\u2013690 (2011)","journal-title":"Endocr. Pract."},{"key":"1847_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/EJE-16-0623","volume":"176","author":"E Les\u00e9n","year":"2017","unstructured":"E. Les\u00e9n, D. Granfeldt, A. Houchard et al. Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study. Eur. J. Endocrinol. 176, 203\u2013212 (2017)","journal-title":"Eur. J. Endocrinol."},{"key":"1847_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11102-018-0913-3","volume":"21","author":"DJ Lobatto","year":"2018","unstructured":"D.J. Lobatto, A.N.V. Steffens, A.H. Zamanipoor Najafabadi et al. Work disability and its determinants in patients with pituitary tumor-related disease. Pituitary 21, 593\u2013604 (2018)","journal-title":"Pituitary"},{"key":"1847_CR14","volume-title":"2016\u2013Editie 2017\/\u201918, Centraal Bureau voor de Statistiek","author":"Standaard Onderwijsindeling.","year":"2018","unstructured":"Standaard Onderwijsindeling. 2016\u2013Editie 2017\/\u201918, Centraal Bureau voor de Statistiek (Den Haag\/Heerlen, The Netherlands, 2018)"},{"key":"1847_CR15","unstructured":"UNESCO Institute for Statistics, International Standard Classification of Education, ISCED-F 2013 (UNESCO Institute for Statistics, Montreal, Canada, 2014)"},{"key":"1847_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11102-016-0707-4","volume":"19","author":"CD Andela","year":"2016","unstructured":"C.D. Andela, M. Scharloo, S. Ramondt et al. The development and validation of the Leiden Bother and Needs Questionnaire for patients with pituitary disease: the LBNQ-Pituitary. Pituitary 19, 293\u2013302 (2016)","journal-title":"Pituitary"},{"key":"1847_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"J.E. Ware, C.D. Sherbourne, The MOS 36-ltem short-form health survey (SF-36). Med. Care 30, 473\u2013483 (1992)","journal-title":"Med. Care"},{"key":"1847_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQoL Group","year":"1990","unstructured":"EuroQoL Group, EuroQol-a new facility for the measurement of health-related quality of life. Health Policy (New York) 16, 199\u2013208 (1990)","journal-title":"Health Policy (New York)"},{"key":"1847_CR19","unstructured":"L. Hakkaart-van Roijen, N. van der Linden, C. Bouwmans, et al. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg (Zorginstituut Nederland, The Netherlands, 2016)"},{"key":"1847_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-70","volume":"8","author":"I Shrier","year":"2008","unstructured":"I. Shrier, R.W. Platt, Reducing bias through directed acyclic graphs. BMC Med. Res. Methodol. 8, 70 (2008)","journal-title":"BMC Med. Res. Methodol."},{"key":"1847_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-356","volume":"14","author":"M Panagioti","year":"2014","unstructured":"M. Panagioti, G. Richardson, N. Small et al. Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv. Res. 14, 356 (2014)","journal-title":"BMC Health Serv. Res."},{"key":"1847_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-16-1015","volume":"177","author":"CD Andela","year":"2017","unstructured":"C.D. Andela, H. Repping-Wuts, N.M.M.L. Stikkelbroeck et al. Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial. Eur. J. Endocrinol. 177, 59\u201372 (2017)","journal-title":"Eur. J. Endocrinol."},{"key":"1847_CR23","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/jama.2018.1150","volume":"319","author":"I Papanicolas","year":"2018","unstructured":"I. Papanicolas, L.R. Woskie, A.K. Jha, Health care spending in the United States and other high-income countries. JAMA 319, 1024 (2018)","journal-title":"JAMA"},{"key":"1847_CR24","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10198-017-0947-x","volume":"19","author":"LI Lier van","year":"2017","unstructured":"L.I. van Lier, J.E. Bosmans, H.P.J. van Hout et al. Consensus-based cross-European recommendations for the identification, measurement and valuation of costs in health economic evaluations: a European Delphi study. Eur. J. Heal. Econ. 19, 993\u20131008 (2017)","journal-title":"Eur. J. Heal. Econ."},{"key":"1847_CR25","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0149-2918(00)88295-8","volume":"21","author":"J Xuan","year":"1999","unstructured":"J. Xuan, L.J. Kirchdoerfer, J.G. Boyer, G.J. Norwood, Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data. Clin. Ther. 21, 383\u2013403 (1999)","journal-title":"Clin. Ther."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01847-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-01847-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01847-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:22:20Z","timestamp":1584750140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-01847-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-01847-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}